COSCIENS Biopharma Inc. (CSCIF) Gross margin 2016–2025
COSCIENS Biopharma Inc. (CSCIF) gross margin by fiscal year — reported gross profit divided by reported revenue.
35.3%FY2025 · since FY2016: 100.0% → 35.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 35.3% | -14.0 pp |
| FY2024 | 49.3% | +8.2 pp |
| FY2023 | 41.1% | -17.6 pp |
| FY2022 | 58.7% | — |
| FY2018 | 92.2% | -7.8 pp |
| FY2017 | 100.0% | +0.0 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice